FDA accepts BLA for INO-3107, a DNA immunotherapy for HPV-6 and HPV-11-associated recurrent respiratory papillomatosis.

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

In a Quebec courtroom last October, Sylvie Desjardins delivered a message to her daughter’s killer that was 30 years in the making. “You thought you were taking a life, but in truth, ...